The ABO blood group locus and a chromosome 3 gene cluster associate with SARS-CoV-2 respiratory failure in an Italian-Spanish genome-wide association analysis

David Ellinghaus,Frauke Degenhardt,Luis Bujanda,Maria Buti,Agustín Albillos,Pietro Invernizzi,Javier Fernández,Daniele Prati,Guido Baselli,Rosanna Asselta,Marit M Grimsrud,Chiara Milani,Fátima Aziz,Jan Kässens,Sandra May,Mareike Wendorff,Lars Wienbrandt,Florian Uellendahl-Werth,Tenghao Zheng,Xiaoli Yi,Raúl de Pablo,Adolfo Garrido Chercoles,Graduate in Chemistry,Adriana Palom,Alba-Estela Garcia-Fernandez,Francisco Rodriguez-Frias,Alberto Zanella,Alessandra Bandera,Alessandro Protti,Alessio Aghemo,Ana Lleo,Andrea Biondi,Andrea Caballero-Garralda,Andrea Gori,Anja Tanck,Anna Latiano,Anna Ludovica Fracanzani,Anna Peschuk,Antonio Julià,Antonio Pesenti,Antonio Voza,David Jiménez,Beatriz Mateos,Beatriz Nafria Jimenez,Graduate in Biotechnology,Carmen Quereda,Claudio Angelini,Cristina Cea,Aurora Solier,David Pestaña,Elena Sandoval,Elvezia Maria Paraboschi,Enrique Navas,Ferruccio Ceriotti,Filippo Martinelli-Boneschi,Flora Peyvandi,Francesco Blasi,Luis Téllez,Albert Blanco-Grau,Giacomo Grasselli,Giorgio Costantino,Giulia Cardamone,Giuseppe Foti,Serena Aneli,Hayato Kurihara,Hesham ElAbd,Ilaria My,Javier Martin,Jeanette Erdmann,José Ferrusquía-Acosta,Koldo Garcia-Etxebarria,Laura Izquierdo-Sanchez,Graduate in Biochemistry,Laura Rachele Bettini,Leonardo Terranova,Leticia Moreira,Luigi Santoro,Luigia Scudeller,Francisco Mesonero,Luisa Roade,Marco Schaefer,Maria Carrabba,Maria del Mar Riveiro Barciela,Maria Eloina Figuera Basso,Maria Grazia Valsecchi,María Hernandez-Tejero,Marialbert Acosta-Herrera,Mariella D’Angiò,Marina Baldini,Marina Cazzaniga,Martin Schulzky,Maurizio Cecconi,Michael Wittig,Michele Ciccarelli,Miguel Rodríguez-Gandía,Monica Bocciolone,Monica Miozzo,Nicole Braun,Nilda Martínez,Orazio Palmieri,Paola Faverio,Paoletta Preatoni,Paolo Bonfanti,Paolo Omodei,Paolo Tentorio,Pedro Castro,Pedro M. Rodrigues,Aaron Blandino Ortiz,Ricardo Ferrer Roca,Roberta Gualtierotti,Rosa Nieto,Salvatore Badalamenti,Sara Marsal,Giuseppe Matullo,Serena Pelusi,Valter Monzani,Tanja Wesse,Tomas Pumarola,Valeria Rimoldi,Silvano Bosari,Wolfgang Albrecht,Wolfgang Peter,Manuel Romero Gómez,Mauro D’Amato,Stefano Duga,Jesus M. Banales,Johannes R Hov,Trine Folseraas,Luca Valenti,Andre Franke,Tom H Karlsen,,,
DOI: https://doi.org/10.1101/2020.05.31.20114991
2020-06-02
Abstract:ABSTRACT Background Respiratory failure is a key feature of severe Covid-19 and a critical driver of mortality, but for reasons poorly defined affects less than 10% of SARS-CoV-2 infected patients. Methods We included 1,980 patients with Covid-19 respiratory failure at seven centers in the Italian and Spanish epicenters of the SARS-CoV-2 pandemic in Europe (Milan, Monza, Madrid, San Sebastian and Barcelona) for a genome-wide association analysis. After quality control and exclusion of population outliers, 835 patients and 1,255 population-derived controls from Italy, and 775 patients and 950 controls from Spain were included in the final analysis. In total we analyzed 8,582,968 single-nucleotide polymorphisms (SNPs) and conducted a meta-analysis of both case-control panels. Results We detected cross-replicating associations with rs11385942 at chromosome 3p21.31 and rs657152 at 9q34, which were genome-wide significant (P<5×10 −8 ) in the meta-analysis of both study panels, odds ratio [OR], 1.77; 95% confidence interval [CI], 1.48 to 2.11; P=1.14×10 −10 and OR 1.32 (95% CI, 1.20 to 1.47; P=4.95×10 −8 ), respectively. Among six genes at 3p21.31, SLC6A20 encodes a known interaction partner with angiotensin converting enzyme 2 (ACE2). The association signal at 9q34 was located at the ABO blood group locus and a blood-group-specific analysis showed higher risk for A-positive individuals (OR=1.45, 95% CI, 1.20 to 1.75, P=1.48×10 −4 ) and a protective effect for blood group O (OR=0.65, 95% CI, 0.53 to 0.79, P=1.06×10 −5 ). Conclusions We herein report the first robust genetic susceptibility loci for the development of respiratory failure in Covid-19. Identified variants may help guide targeted exploration of severe Covid-19 pathophysiology.
What problem does this paper attempt to address?